BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12240481)

  • 1. Implantable defibrillator malfunctions should not be overlooked.
    Hogle WP
    Clin J Oncol Nurs; 2002; 6(5):252. PubMed ID: 12240481
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator storm: nursing care issues for patients and families.
    O'Brien MC; Langberg J; Valderrama AL; Kirkendoll K; Romeiko N; Dunbar SB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):9-16, ix. PubMed ID: 15749396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
    Friedewald VE; Fonarow GC; Olshansky B; Yancy CW; Roberts WC
    Am J Cardiol; 2011 Feb; 107(4):583-90. PubMed ID: 21295175
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease.
    Borleffs CJ; van Welsenes GH; van Bommel RJ; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Rosendaal FR; Schalij MJ
    Eur Heart J; 2010 Mar; 31(6):712-8. PubMed ID: 19933693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of sudden death--afraid of the truth].
    Meyer FP
    Dtsch Med Wochenschr; 2003 Mar; 128(10):514; author reply 514. PubMed ID: 12627348
    [No Abstract]   [Full Text] [Related]  

  • 10. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the implantable cardiac defibrillator be used for primary prevention of sudden death? A review of the issues relevant to hospital decision making.
    McGregor M; Chen J
    Can J Cardiol; 2004 Oct; 20(12):1199-204. PubMed ID: 15494771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?
    Amin MS; Ellenbogen KA
    Curr Opin Cardiol; 2010 Jan; 25(1):23-8. PubMed ID: 19907318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pacemaker malfunctions in Danon's disease.
    Marras E; Sciarra L; Bocchino M; Delise P
    Pacing Clin Electrophysiol; 2008 Jan; 31(1):125-8. PubMed ID: 18181922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 17. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary prevention of sudden death - afraid of the truth].
    Klein H
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary prevention of sudden cardiac death. do we need to implant a defibrillator in all the patients with low ejection fraction?
    Disertori M; El-Sherif N
    Ital Heart J; 2004 Sep; 5(9):643-7. PubMed ID: 15568590
    [No Abstract]   [Full Text] [Related]  

  • 20. Recall alerts in implantable cardioverter-defibrillator recipients: implications for patients and physicians.
    Schwartz J; Blangy H; Zinzius PY; Freysz L; Aliot E; Sadoul N
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):96-103. PubMed ID: 21039641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.